| Nov 15 |
GT Biopharma GAAP EPS of -$1.53
|
| Nov 14 |
GT Biopharma Reports Third Quarter 2024 Financial Results
|
| Sep 26 |
GT Biopharma to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
|
| Sep 24 |
GT Biopharma to Host Virtual KOL Event Showcasing its NK Cell Engager Pipeline and Broad Indication Potential on October 10, 2024
|
| Aug 15 |
GT Biopharma GAAP EPS of -$2.17
|
| Aug 14 |
GT Biopharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update
|
| Jun 20 |
GT Biopharma files to sell 740,000 shares by holders
|
| May 21 |
GT Biopharma stock falls on $3.2M equity raise
|
| May 21 |
GT Biopharma, Inc. Announces $3.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
|
